Washington, DC or Virtual
The 2023 Food and Drug Law Institute's Annual Conference will be held May 17-18, 2023. As the premier conference for the food and drug law community, the meeting brings together experts from federal government, industry, the private bar, non-profit, patient and consumer advocates, consulting organizations, and academia to address complex legal, regulatory, compliance, and policy issues in all facets of the FDA-regulated industry.
Morrison Foerster is a proud sponsor of the conference and partner Stacy Amin is moderating a panel on "FDA Under Fire: What Recent Cases Mean for FDA Regulation," on Wednesday, May 17. Several important cases and decisions related to agency authority, deference, and reviewability of FDA actions have been published over the past year. In this session, speakers will discuss how these cases could impact FDA product approval, agency statutory interpretation, established agency policy, and the availability of remedies under the Administrative Procedure Act. Speakers also will address how HHS’s Office of General Counsel and FDA’s Office of Chief Counsel may construe the scope of these cases, and what changes in FDA jurisprudence could mean for industry and FDA moving forward.
For more information, visit the FDLI website.
Industries + Issues